IGF-1 LR3 Peptide (1 mg) – Product Description
IGF1-LR3 is a modified insulin-like growth factor research peptide commonly used in controlled laboratory studies investigating IGF receptor signaling, downstream anabolic pathway activation, and tissue-level growth-factor biology. The “LR3” format is typically discussed in research contexts for its altered receptor-binding and kinetic profile versus native IGF-1, making it a frequently selected tool compound for protocol-driven IGF pathway exploration.
This product is supplied exclusively for laboratory research applications and is supported by third-party analytical testing documentation to help research teams maintain strong internal quality controls and reproducibility standards.
IGF-1 LR3 Research Peptide Specifications:
| Unit Size |
1 mg/vial |
| Unit Quantity |
1 vial |
| Purity (HPLC) |
See lot-specific COA for verified purity and analytical methods |
| Identity Verification |
See lot-specific COA for mass spectrometry confirmation and method details |
| Sequence / Molecular Data |
See lot-specific COA for sequence confirmation references and molecular characterization |
| Appearance |
Lyophilized Powder |
| Source |
Chemical Synthesis |
| Storage Conditions |
Store lyophilized IGF-1 LR3 at −20 °C or below, protected from light and moisture. Reconstituted solutions should be stored at 2–8 °C and used in accordance with institutional stability guidance and study requirements. |
| Research Use Only |
Supplied exclusively for laboratory research use. Not for human consumption, clinical use, or veterinary applications. |
What Is IGF-1 LR3? Research Background and Mechanism
Insulin-like growth factor (IGF) signaling is a core pathway in cellular growth, differentiation, and nutrient-partitioning biology. In preclinical and in vitro research, IGF-related compounds are often used to study receptor-mediated signaling cascades (such as PI3K/AKT and MAPK pathway activity), changes in protein synthesis markers, and shifts in cell growth behavior under controlled stimulus conditions.
IGF-1 LR3 is frequently positioned as a practical laboratory tool because it is referenced in the literature as having an altered interaction profile compared to native IGF-1. In experimental design, researchers may use IGF-1 LR3 to create a consistent, measurable IGF-axis stimulus for pathway mapping, comparative receptor response testing, and tissue-specific signaling studies.
Important Research Notice: Nordsci peptides are supported by independent third-party analytical testing to validate identity and purity via methods such as HPLC and mass spectrometry. A Certificate of Analysis (COA) is available for each lot to support protocol files, QC workflows, and documentation requirements.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
IGF-1 LR3 Research: Key Laboratory Applications
1. IGF Receptor Signaling and Downstream Pathway Mapping
IGF-1 LR3 is commonly used in mechanistic research to evaluate IGF receptor activation and downstream signaling behavior. Studies frequently track pathway-level readouts such as phosphorylation markers, gene expression changes, and time-dependent signaling kinetics across cell lines or tissue samples.
In programs where growth-factor signaling is evaluated alongside GH-axis stimulation models, labs often benchmark IGF signaling tools against upstream secretagogue frameworks such as Sermorelin or CJC 1295 (without DAC) in separate arms to preserve interpretability.
2. Protein Synthesis Markers and Cellular Growth-Response Models
In controlled models, investigators may include IGF-1 LR3 when studying cellular growth-response behavior under standardized nutrient conditions. Research endpoints can include protein synthesis markers, cellular hypertrophy signals, and comparative response curves between different stimulus intensities or exposure windows.
These models are typically designed with strict controls to separate signaling effects from confounders such as serum variability, baseline metabolic stress, or cell-cycle differences.
3. Tissue-Level Growth-Factor Biology and Recovery-Adjacent Research Endpoints
In animal and tissue models, IGF-axis signaling is often evaluated in the context of remodeling and recovery-adjacent biology. IGF-1 LR3 may be used as a signaling probe in studies tracking tissue adaptation markers, growth-factor-related transcription patterns, and structural pathway activity in response to controlled stressors or interventions.
Where tissue integrity and repair signaling are also being investigated, some labs evaluate related tool compounds (in separate arms) such as BPC 157 or Thymosin Beta 4 to isolate repair-pathway endpoints from growth-factor endpoints.
4. Comparative Signaling Studies Within Multi-Compound Research Programs
IGF-1 LR3 is frequently integrated into larger research programs as a comparator compound to help distinguish upstream endocrine stimulation from downstream IGF-axis signaling. In these designs, the goal is typically clarity: determining whether observed effects are best explained by GH release dynamics, receptor-level IGF stimulation, or downstream transcriptional shifts.
Run Cleaner IGF-Axis Experiments With Documented Inputs
Standardized sourcing and lot-level COAs reduce variability when you are running multi-arm signaling studies and comparing cohorts over time.
Shop all peptides
IGF-1 LR3 Certificate of Analysis (COA) – Lab Testing
Each lot of IGF-1 LR3 is supported by a Certificate of Analysis documenting identity and analytical characterization. COA documentation can be used for protocol files, internal QC review, or procurement documentation where research teams require traceable inputs for multi-phase study execution.
Where to Buy IGF-1 LR3 for Research Purposes
Sourcing IGF-1 LR3 for institutional use requires a supplier with robust documentation, consistent labeling, and repeatable quality controls. Nordsci Peptides focuses on research-grade peptides supported by third-party testing and lot traceability, enabling labs to execute protocol-driven research with reliable inputs.
IMPORTANT: IGF-1 LR3 is sold exclusively for in vitro and preclinical research applications. It is not approved for human use or any therapeutic purpose. Researchers are responsible for complying with all applicable regulations and institutional policies governing peptide research in their jurisdiction.
Scale Your Growth-Factor Research Pipeline
Build more repeatable datasets with research-grade peptides supported by transparent COAs and lot tracking.
Shop all peptides
Scientific References
- Peer-reviewed literature on insulin-like growth factor (IGF) receptor biology and downstream signaling pathways (PI3K/AKT, MAPK) used in preclinical and in vitro research.
- Research literature comparing native IGF-1 signaling behavior to modified IGF analogs used in laboratory models, including kinetic and receptor-interaction discussions.
- Preclinical studies evaluating growth-factor signaling readouts, protein synthesis markers, and tissue-level adaptation endpoints under controlled experimental conditions.
- Methodology references on peptide handling, stability-aware storage, aliquoting practices, and analytical verification via HPLC and mass spectrometry.
- Laboratory best practices for documentation: COA archiving, lot traceability, and SOP-driven procurement workflows for reproducible research.